BridgeMD
New treatment option for Primary Immunodeficiency
Official title Investigation of the Effects of Pulmonary Rehabilitation in Children With Primary Immunodeficiency
ClinicalTrials.gov ID: NCT06092528
What this study is testing
- What it's testing
- Primary immunodeficiencies (PID) are a heterogeneous group of diseases that occur as a result of disorders that affect the development, differentiation and/or function of various cells and building blocks in the immune system. Among the symptoms and complications of PID, pulmonary complications are very common and significantly increase the morbidity and mortality of the disease.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 6 to 18
You may be able to join if
- -Patients aged 6-18 years with primary immunodeficiency
You likely can't join if
- Acute pulmonary exacerbation, acute upper or lower respiratory tract infection
- Serious neurological, neuromuscular, orthopedic and other systemic diseases or other diseases affecting physical functions
- Participating in a planned exercise program in the past three months
- Cognitive impairment, which may cause difficulty understanding and following exercise test instructions
The study team makes the final eligibility decision.
Where it's taking place
- Ankara, Çankaya, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 6 years to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ankara, Çankaya, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.